Metabolism of benzbromarone in man: structures of new oxidative metabolites, 6-hydroxy- and 1″-oxo-benzbromarone, and the enantioselective formation and elimination of 1″-hydroxybenzbromarone

References

• Arnold P. J., Guserle R., Luckow V., Hemmer R., Grote H. Liquid chromatography-mass spectrometry in metabolic research. I. Metabolites of benzbromarone in human plasma and urine. Journal of Chromatography 1991; 544: 267–280
   Google Scholar
• Broekhuysen J., Pacco M., Sion R., Demeulenaere L., Van Hee M. Metabolism of Benzbromarone in man. Journal of Clinical Pharmacology 1972; 4: 125–130
   Google Scholar
• Cainelli G., Cardillo G., Orena M., Sandri S. Polymer supported reagents. Chromic acid on anion exchange resins. A simple and practical oxidation of alcohols to aldehydes and ketones. Journal of the American Chemical Society 1976; 98: 6737–6738
   Web of Science ®Google Scholar
• Dayer P., Gasser R., Gut J., Kronbach T., Robertz G. M., Eichelbaum M., Meyer U. Characterisation of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism)—increased Michaelis constant (Km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizers. Biochemical and Biophysical Research Communications 1984; 125: 374–380
   PubMed Web of Science ®Google Scholar
• De Vries J. X., Schmitz-Kummer E., Weber E. The separation of the enantiomers of coumarin anticoagulants and their metabolites by HPLC. Naunyn-Schmiedeberg's Archives of Pharmacology 1992a; 345: R73, Suppl. 2
   Google Scholar
• De Vries J. X., Simon M., Zimmermann R., Harenberg J. Identification of phenpro-coumon metabolites in human urine by high-performance liquid chromatography and gas chromatography mass spectrometry. Journal of Chromatography 1985; 338: 325–334
   Google Scholar
• De Vries J. X., Voss A., Walter-Sack I., Rudi J., Raedsch R., Weber E. New oxidative metabolites of benzbromarone. Their characterisation in plasma after administration of benzbromarone to humans, and in vitro after incubation with human and rat liver microsomes. Naunyn-Schmiedeberg's Archives of Pharmacology 1991; 344: R138, Suppl. 2
   Google Scholar
• De Vries J. X., Voss A., Walter-Sack I., Weber E., Rudi J., Spraul M., Ackermann M. Structure elucidation of 6-hydroxybenzbromarone and the enantioselective formation of 1′-hydroxybenzbromarone, main metabolites isolated from human urine. Naunyn-Schmiedeberg's Archives of Pharmacology 1992b; 345: R73, Suppl. 2
   Google Scholar
• De Vries J. X., Walter-Sack I., Ittensohn A. Analysis of benzbromarone in human plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. Journal of Chromatography 1987; 417: 420–427
   PubMed Web of Science ®Google Scholar
• De Vries J. X., Walter-Sack I., Ittensohn A., Weber E. The isolation, identification and structure of a new hydroxylated metabolite of benzbromarone in man. Xenobiotica 1989; 19: 1461–1470
   Web of Science ®Google Scholar
• De Vries J. X., Walter-Sack I., Ittensohn A., Weber E., Empl H., Gresser U., Zöllner N. Benzbromarone hydroxylation in man: defective formation of the 6-hydroxybenzbromarone metabolite. The Clinical Investigator 1993; 73, manuscript accepted for publication
   Google Scholar
• Friebolin H. Ein und zweidimensionale NMR-Spektroskopie. VCH Weinheim, Eine Einfühung 1988; 133
   Google Scholar
• Greenlee W. F., Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity; induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital. 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Pharmacology and Experimental Therapeutics 1978; 205: 596–605
   PubMed Web of Science ®Google Scholar
• Heimark L. D., Toon S., Low L. K., Swinney D. C., Trager W. F. The synthesis of deuterium labelled metabolites of warfarin and phenprocoumon. Journal of Labelled Compounds and Radiopharmaceuticals 1986; 23: 137–148
   Google Scholar
• Ittensohn A., De Vries J. X., Raedsch R., Walter-Sack I., Weber E. Biliary excretion of benzbromarone and metabolites in man. Falk Symposium No. 57. Hepatic Metabolism and Disposition of Endo- and Xenobiotics 1990, Freiburg/Br. 8–10.10. Abstract 38
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Maurer H., Wollenberg P. Urinary metabolites of benzbromarone in man. Arzneimittel-Forschung/Drug Research 1990; 40(I)460–462
   Google Scholar
• Mc Lafferty F. W. Interpretation of Mass Spectra3rd Edn. University Science Books, Mill Valley, CA 1980; 17, Chapter 2
   Google Scholar
• Rudi J., Ittensohn A., De Vries J. X., Raedsch R., Walter-Sack I., Weber E., Kommerell B. The in vitro microsomal hydroxylation of benzbromarone by human and rat liver. Hepatology 1991b; 14(II)235
   Google Scholar
• Rudi J., Ittensohn A., Voss A., De Vries J. X., Raedsch R., Walter-Sack I., Weber E., Kommerell B. The oxidative metabolism of benzbromarone by liver microsomes. European Journal of Gastroenterology and Hepatology 1991a; 3: 50, Suppl. 1
   Google Scholar
• Walter-Sack I., De Vries J. X., Ittensohn A., Weber E. Rapid and slow benzbromarone elimination phenotypes in man—benzbromarone and metabolite profiles. European Journal of Clinical Pharmacology 1990b; 39: 577–581
   Google Scholar
• Walter-Sack I., Eichelbaum M., De Vries J. X., Weber E. Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine. Klinische Wochenschrift 1988; 66: 1097–1098
   Google Scholar
• Walter-Sack I., Gresser U., Adjan M., Kamilli I., Ittensohn A., De Vries J. X., Weber E., Zöllner N. Variation of benzbromarone elimination in man—a population study. European Journal of Clinical Pharmacology 1990a; 39: 173–176
   Google Scholar
• Zöllner N., Gresser U. Deficient benzbromarone elimination from plasma: evidence for a new genetically determined polymorphism with an autosomal recessive inheritance. International Journal of Purine and Pyrimidine Research 1991; 2: A211, Suppl. 1
   Google Scholar
• Zöllner N., Gresser U., Walter-Sack I. Deficient benzbromarone elimination: a familial disorder?. Klinische Wochenschrift 1990; 68: 101
   Google Scholar